Generics Manufacturing, Stockpiling Before IP Expiries Could Boost EU
This article was originally published in The Pink Sheet Daily
Executive Summary
If generics firms were permitted to manufacture and stockpile products ahead of IP expiries, it’s estimated they could add almost €4.5 billion ($6.3 billion) to the EU economy over nine years.